Literature DB >> 23667209

Penile cancer: Clinical Practice Guidelines in Oncology.

Peter E Clark, Philippe E Spiess, Neeraj Agarwal, Matthew C Biagioli, Mario A Eisenberger, Richard E Greenberg, Harry W Herr, Brant A Inman, Deborah A Kuban, Timothy M Kuzel, Subodh M Lele, Jeff Michalski, Lance Pagliaro, Sumanta K Pal, Anthony Patterson, Elizabeth R Plimack, Kamal S Pohar, Michael P Porter, Jerome P Richie, Wade J Sexton, William U Shipley, Eric J Small, Donald L Trump, Geoffrey Wile, Timothy G Wilson, Mary Dwyer, Maria Ho.   

Abstract

Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the United States and other developed countries. Although rare, it is associated with significant disfigurement, and only half of the patients survive beyond 5 years. Proper evaluation of both the primary lesion and lymph nodes is critical, because nodal involvement is the most important factor of survival. The NCCN Clinical Practice Guidelines in Oncology for Penile Cancer provide recommendations on the diagnosis and management of this devastating disease based on evidence and expert consensus.

Entities:  

Mesh:

Year:  2013        PMID: 23667209      PMCID: PMC4042432          DOI: 10.6004/jnccn.2013.0075

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  100 in total

1.  Bilateral ilioinguinal lymph node dissection in the management of cancer of the penis.

Authors:  J E Pow-Sang; V Benavente; J M Pow-Sang; M Pow-Sang
Journal:  Semin Surg Oncol       Date:  1990

2.  Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma.

Authors:  A Lopes; B M Rossi; F P Fonseca; S Morini
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

3.  Re: Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results.

Authors:  W J Catalona
Journal:  J Urol       Date:  1988-10       Impact factor: 7.450

4.  Interstitial brachytherapy for penile cancer: an alternative to amputation.

Authors:  Juanita Crook; Laval Grimard; John Tsihlias; Chris Morash; Tony Panzarella
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

5.  Trends in cancer risk among people with AIDS in the United States 1980-2002.

Authors:  Eric A Engels; Ruth M Pfeiffer; James J Goedert; Phillip Virgo; Timothy S McNeel; Steven M Scoppa; Robert J Biggar
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

Review 6.  Penile cancer: review of the recent literature.

Authors:  Igor Stancik; Wolfgang Höltl
Journal:  Curr Opin Urol       Date:  2003-11       Impact factor: 2.309

Review 7.  Multimodality therapy in penile cancer: when and which treatments?

Authors:  Lance C Pagliaro; Juanita Crook
Journal:  World J Urol       Date:  2008-08-06       Impact factor: 4.226

8.  Radiation therapy in the management of the primary penile tumor: an update.

Authors:  Juanita Crook; Clement Ma; Laval Grimard
Journal:  World J Urol       Date:  2008-07-18       Impact factor: 4.226

9.  Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation.

Authors:  Philippe E Spiess; Jonathan I Izawa; Roland Bassett; Daniel Kedar; Joseph E Busby; Franklin Wong; Teresa Eddings; Pheroze Tamboli; Curtis A Pettaway
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

10.  Outcome of glansectomy and skin grafting in the management of penile cancer.

Authors:  Hugh F O'Kane; Ajay Pahuja; K J Ho; Ali Thwaini; Thaigarajan Nambirajan; Patrick Keane
Journal:  Adv Urol       Date:  2011-04-04
View more
  44 in total

Review 1.  Contemporary management of patients with penile cancer and lymph node metastasis.

Authors:  Andrew Leone; Gregory J Diorio; Curtis Pettaway; Viraj Master; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

Review 2.  Current Management Strategy for Penile Cancer and Future Directions.

Authors:  Tanya B Dorff; Leslie K Ballas; Anne K Schuckman
Journal:  Curr Oncol Rep       Date:  2017-08       Impact factor: 5.075

3.  Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study.

Authors:  Dominic H Tang; Rosa Djajadiningrat; Gregory Diorio; Juan Chipollini; Zhenjun Ma; Braydon J Schaible; Mario Catanzaro; Dingwei Ye; Yao Zhu; Nicola Nicolai; Simon Horenblas; Peter A S Johnstone; Philippe E Spiess
Journal:  Urol Oncol       Date:  2017-06-27       Impact factor: 3.498

Review 4.  Penile preserving and reconstructive surgery in the management of penile cancer.

Authors:  Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2016-03-22       Impact factor: 14.432

5.  Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.

Authors:  Shreyas S Joshi; Elizabeth Handorf; David Strauss; Andres F Correa; Alexander Kutikov; David Y T Chen; Rosalia Viterbo; Richard E Greenberg; Robert G Uzzo; Marc C Smaldone; Daniel M Geynisman
Journal:  JAMA Oncol       Date:  2018-05-01       Impact factor: 31.777

Review 6.  [Reconstructive surgery in penile cancer].

Authors:  M Sohn; M Dietrich; A Wirthmann; U M Rieger
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

7.  Penile cancer: impact of age at diagnosis on morphology and prognosis.

Authors:  Geise Rezende Paiva; Iguaracyra Barreto de Oliveira Araújo; Daniel Abensur Athanazio; Luiz Antonio Rodrigues de Freitas
Journal:  Int Urol Nephrol       Date:  2014-11-11       Impact factor: 2.370

8.  Extent of pelvic lymph node dissection in penile cancer may impact survival.

Authors:  Kamran Zargar-Shoshtari; Pranav Sharma; Rosa Djajadiningrat; Mario Catanzaro; Ding-Wei Ye; Yao Zhu; Nicola Nicolai; Simon Horenblas; Philippe E Spiess
Journal:  World J Urol       Date:  2015-05-31       Impact factor: 4.226

9.  Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial.

Authors:  Benjamin T Ristau; Judi Manola; Naomi B Haas; Daniel Y C Heng; Edward M Messing; Christopher G Wood; Christopher J Kane; Robert S DiPaola; Robert G Uzzo
Journal:  J Urol       Date:  2017-07-18       Impact factor: 7.450

10.  18F-FDG PET/CT as a prognostic factor in penile cancer.

Authors:  André Salazar; Eduardo Paulino Júnior; Paulo Guilherme O Salles; Raul Silva-Filho; Edna A Reis; Marcelo Mamede
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-24       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.